PMID: 2497493Jan 1, 1989Paper

Studies on the discriminative stimulus properties of apomorphine in rhesus monkeys

Psychopharmacology
A H Tang, R A Code

Abstract

Four rhesus monkeys were trained to discriminate the effect of apomorphine (0.1 mg/kg IM) from that of saline injections. The discriminative stimulus (DS) effect of apomorphine generalized to the dopamine D2 receptor agonist quinpirole. The D1 dopamine receptor agonist SKF 38393 elicited responses only on the saline-appropriate lever. Stimulus generalization of the dopamine autoreceptor agonist 3-PPP exhibited stereospecificity favoring the (+) over the (-) isomer. d-Amphetamine, phencyclidine, 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), and clonidine did not share the DS effect of apomorphine. The D2-selective antagonists sulpiride and metoclopramide reversed both the DS effect and the response rate reduction produced by the training dose of apomorphine. Chlorpromazine and the D1 antagonist Sch 23390 also antagonized the DS effect, but the antagonism was accompanied by a further rate reduction. Haloperidol and clozapine antagonized the DS effect incompletely. The DS effect produced by apomorphine in this study appears to be mediated predominantly by post-synaptic D2 receptor activation, with contribution also from the D1 receptor.

References

May 1, 1979·Neuropharmacology·A D PolingJ B Appel
Nov 1, 1975·Pharmacology, Biochemistry, and Behavior·B T Ho, J T Huang
Jan 1, 1986·Advances in Experimental Medicine and Biology·P H Andersen, E B Nielsen
Dec 10, 1985·European Journal of Pharmacology·K A CunninghamJ B Appel
Dec 2, 1986·European Journal of Pharmacology·R T Weathersby, J B Appel
May 15, 1985·Biochemical Pharmacology·S BoyceC D Marsden
Jan 1, 1987·Psychopharmacology·A H Tang, S R Franklin
Apr 1, 1985·Pharmacology, Biochemistry, and Behavior·W L WoolvertonL I Goldberg
Jan 1, 1983·Journal of Neural Transmission·A Carlsson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here